Schedule 13G ownership disclosure
*MIDATECH PHARMA PLC
Security class unavailable · CUSIP: 59564R104
Event date: 2017-08-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,043,164
- Percent of class
- 6.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-17-005477
- Form type
- SC 13G
- Filer
- Biodexa Pharmaceuticals Plc
- CIK
- CIK 1643918
- Filed
- Sep 05, 2017
- Reporting period
- Aug 25, 2017
- Description
- Schedule 13G beneficial ownership